NLRP3 and COVID-19: In COVID-19 patients, particularly those who experience severe infection or long COVID, the activation of the NLRP3 inflammasome may perpetuate this chronic inflammatory state, leading to immune exhaustion, neuroinflammation, and worsening of age-related conditions.